These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases. Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264 [TBL] [Abstract][Full Text] [Related]
4. Squamous variant of gallbladder cancer: is it different from adenocarcinoma? Kalayarasan R; Javed A; Sakhuja P; Agarwal AK Am J Surg; 2013 Sep; 206(3):380-5. PubMed ID: 23827515 [TBL] [Abstract][Full Text] [Related]
5. Hyalinizing cholecystitis and associated carcinomas: clinicopathologic analysis of a distinctive variant of cholecystitis with porcelain-like features and accompanying diagnostically challenging carcinomas. Patel S; Roa JC; Tapia O; Dursun N; Bagci P; Basturk O; Cakir A; Losada H; Sarmiento J; Adsay V Am J Surg Pathol; 2011 Aug; 35(8):1104-13. PubMed ID: 21716080 [TBL] [Abstract][Full Text] [Related]
6. Role of radical resection in patients with gallbladder carcinoma and jaundice. Feng FL; Liu C; Li B; Zhang BH; Jiang XQ Chin Med J (Engl); 2012 Mar; 125(5):752-6. PubMed ID: 22490568 [TBL] [Abstract][Full Text] [Related]
7. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor. Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346 [TBL] [Abstract][Full Text] [Related]
9. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma. Chen C; Wang L; Liu X; Zhang G; Zhao Y; Geng Z Int J Clin Exp Pathol; 2015; 8(7):8218-26. PubMed ID: 26339390 [TBL] [Abstract][Full Text] [Related]
10. Surgical therapy and prognosis of sarcomatoid carcinoma of the gallbladder. Hu ZH; Li ZW; Shen L; Zhang M; Zheng SS Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):175-9. PubMed ID: 20382590 [TBL] [Abstract][Full Text] [Related]
11. Gallbladder cancer in Chile: Pathologic characteristics of survival and prognostic factors: analysis of 1,366 cases. Roa I; Ibacache G; Muñoz S; de Aretxabala X Am J Clin Pathol; 2014 May; 141(5):675-82. PubMed ID: 24713738 [TBL] [Abstract][Full Text] [Related]
12. Carcinoma involving the gallbladder: a retrospective review of 23 cases - pitfalls in diagnosis of gallbladder carcinoma. Giang TH; Ngoc TT; Hassell LA Diagn Pathol; 2012 Jan; 7():10. PubMed ID: 22284391 [TBL] [Abstract][Full Text] [Related]
13. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience. D'Hondt M; Lapointe R; Benamira Z; Pottel H; Plasse M; Letourneau R; Roy A; Dagenais M; Vandenbroucke-Menu F Eur J Surg Oncol; 2013 Jun; 39(6):548-53. PubMed ID: 23522952 [TBL] [Abstract][Full Text] [Related]
14. Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma. Al-Daraji WI; Makhlouf HR; Miettinen M; Montgomery EA; Goodman ZD; Marwaha JS; Fanburg-Smith JC Am J Surg Pathol; 2009 Jun; 33(6):826-34. PubMed ID: 19194282 [TBL] [Abstract][Full Text] [Related]
15. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma. Xie F; Xu X; Xu A; Liu C; Liang F; Xue M; Bai L Hum Pathol; 2014 Mar; 45(3):513-21. PubMed ID: 24440094 [TBL] [Abstract][Full Text] [Related]
16. Sarcomatoid carcinoma with components of small cell carcinoma and undifferentiated carcinoma of the gallbladder. Takahashi Y; Fukushima J; Fukusato T; Shiga J Pathol Int; 2004 Nov; 54(11):866-71. PubMed ID: 15533231 [TBL] [Abstract][Full Text] [Related]
17. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma. Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659 [TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of survivin expression in gallbladder carcinoma. Salman T; Argon A; Kebat T; Vardar E; Erkan N; Alacacıoğlu A APMIS; 2016 Aug; 124(8):633-8. PubMed ID: 27214404 [TBL] [Abstract][Full Text] [Related]
19. Aberrant p53 expression and the development of gallbladder carcinoma and adenoma. Wang SN; Chung SC; Tsai KB; Chai CY; Chang WT; Kuo KK; Chen JS; Lee KT Kaohsiung J Med Sci; 2006 Feb; 22(2):53-9. PubMed ID: 16568721 [TBL] [Abstract][Full Text] [Related]